MCID: OVR046
MIFTS: 50

Ovarian Cyst

Categories: Endocrine diseases, Reproductive diseases, Cancer diseases

Aliases & Classifications for Ovarian Cyst

MalaCards integrated aliases for Ovarian Cyst:

Name: Ovarian Cyst 12 29 6 15
Ovarian Cysts 55 43 73

Classifications:



External Ids:

Disease Ontology 12 DOID:5119
ICD10 33 N83.2
ICD9CM 35 620.2
SNOMED-CT 68 198586000

Summaries for Ovarian Cyst

MedlinePlus : 43 The ovaries are part of the female reproductive system. They produce a woman's eggs and make female hormones. Ovarian cysts are fluid-filled sacs in or on an ovary. They usually form during ovulation, when the ovary releases an egg. They are usually harmless and go away by themselves. Most women have them sometime during their lives. Most ovarian cysts are small and don't cause symptoms. Women may not find out that they have them until they have a pelvic exam. If there are symptoms, they may include Pressure Bloating Swelling Pain in the lower abdomen, on the side where the cyst is If your health care provider finds a cyst, you may be able to wait to see if it gets bigger. You may need surgery if you have pain, are past menopause, or if the cyst does not go away. If a cyst bursts or causes bleeding, you should get medical help right away. Birth control pills can help prevent new cysts. Rarely, ovarian cysts can become cancerous. This risk increases as you get older. A health problem that involves ovarian cysts is polycystic ovary syndrome (PCOS). Women with PCOS can have high levels of male hormones, irregular or no periods, and small ovarian cysts. Dept. of Health and Human Services Office on Women's Health

MalaCards based summary : Ovarian Cyst, also known as ovarian cysts, is related to corpus luteum cyst and ovarian disease, and has symptoms including pelvic pain An important gene associated with Ovarian Cyst is MUC16 (Mucin 16, Cell Surface Associated), and among its related pathways/superpathways are Fluid shear stress and atherosclerosis and Endochondral Ossification. The drugs Zinc and Orlistat have been mentioned in the context of this disorder. Affiliated tissues include ovary, liver and bone, and related phenotypes are endocrine/exocrine gland and reproductive system

Wikipedia : 76 An ovarian cyst is a fluid-filled sac within the ovary. Often they cause no symptoms. Occasionally they... more...

Related Diseases for Ovarian Cyst

Diseases in the Ovarian Cyst family:

Malignant Ovarian Cyst

Diseases related to Ovarian Cyst via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 138)
# Related Disease Score Top Affiliating Genes
1 corpus luteum cyst 31.7 AFP FOXL2 MUC16
2 ovarian disease 31.7 FOXL2 NOBOX PRL
3 cystadenocarcinoma 29.9 MUC16 VEGFA
4 adenomyosis 29.5 MUC16 PRL VEGFA
5 neonatal ovarian cyst 12.1
6 malignant ovarian cyst 12.1
7 mccune-albright syndrome 11.3
8 fraser-like syndrome 10.9
9 aromatase deficiency 10.9
10 bleeding disorder, platelet-type, 19 10.9
11 autoimmune oophoritis 10.9
12 lipedematous scalp 10.9
13 opisthorchiasis 10.6 AFP MUC16
14 adenomatoid tumor 10.6 AFP MUC16
15 endodermal sinus tumor 10.6 AFP MUC16
16 hydrocele 10.6 AFP VEGFA
17 testicular granulosa cell tumor 10.6 AFP FOXL2
18 juvenile type testicular granulosa cell tumor 10.5 AFP FOXL2
19 peliosis hepatis 10.5 AFP VEGFA
20 primary peritoneal carcinoma 10.5 MUC16 VEGFA
21 telangiectasis 10.5 AFP VEGFA
22 pericardial effusion 10.4 MUC16 VEGFA
23 sex cord-gonadal stromal tumor 10.4 AFP FOXL2
24 serous cystadenocarcinoma 10.4 MUC16 VEGFA
25 peripartum cardiomyopathy 10.4 PRL VEGFA
26 ovarian brenner tumor 10.4 MUC16 PRL
27 placental insufficiency 10.4 AFP VEGFA
28 granulosa cell tumor of the ovary 10.3 FOXL2 PRL
29 pituitary tumors 10.3 PRL VEGFA
30 vein disease 10.3 AFP PLAT
31 ovarian cancer 10.1
32 peritonitis 10.1
33 amenorrhea 10.0 NOBOX PRL
34 meningocele 10.0
35 hypothyroidism 10.0
36 reproductive system disease 9.9 FOXL2 NOBOX PRL
37 premature ovarian failure 1 9.9 FOXL2 NOBOX PRL
38 ectopic pregnancy 9.9
39 breast cancer 9.9
40 aging 9.9
41 leiomyoma 9.9
42 vaginitis 9.9
43 endotheliitis 9.9
44 gingivitis 9.8 PLAT SERPINB2
45 ovarian serous cystadenocarcinoma 9.8 MUC16 VEGFA
46 leiomyoma, uterine 9.8
47 ovarian hyperstimulation syndrome 9.8
48 hydronephrosis 9.8
49 cervicitis 9.8
50 endometriosis 9.8

Graphical network of the top 20 diseases related to Ovarian Cyst:



Diseases related to Ovarian Cyst

Symptoms & Phenotypes for Ovarian Cyst

UMLS symptoms related to Ovarian Cyst:


pelvic pain

MGI Mouse Phenotypes related to Ovarian Cyst:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 endocrine/exocrine gland MP:0005379 9.43 PRL VEGFA AFP FOXL2 NOBOX PLAT
2 reproductive system MP:0005389 9.1 PRL VEGFA AFP FOXL2 NOBOX PLAT

Drugs & Therapeutics for Ovarian Cyst

Drugs for Ovarian Cyst (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 361)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Zinc Approved, Investigational Phase 4,Early Phase 1,Not Applicable 7440-66-6 23994
2
Orlistat Approved, Investigational Phase 4,Phase 2 96829-58-2 3034010
3
Pioglitazone Approved, Investigational Phase 4,Not Applicable,Early Phase 1 111025-46-8 4829
4
Simvastatin Approved Phase 4,Phase 3,Not Applicable 79902-63-9 54454
5
Metformin Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 657-24-9 14219 4091
6
Hydrocortisone Approved, Vet_approved Phase 4,Not Applicable,Early Phase 1 50-23-7 5754
7
Ganirelix Approved Phase 4,Early Phase 1 123246-29-7, 124904-93-4 25081094
8
Drospirenone Approved Phase 4,Phase 3,Phase 1,Not Applicable 67392-87-4 68873
9 Estradiol valerate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 979-32-8
10
Progesterone Approved, Vet_approved Phase 4,Phase 3,Phase 1,Not Applicable,Early Phase 1 57-83-0 5994
11
Letrozole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 112809-51-5 3902
12
Resveratrol Approved, Experimental, Investigational Phase 4,Phase 1,Not Applicable 501-36-0 445154
13
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 50-28-2 5757
14
Testosterone Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 58-22-0 6013
15
Cyproterone Acetate Approved, Investigational Phase 4,Phase 2,Phase 3,Early Phase 1,Not Applicable 427-51-0
16
Ethinyl Estradiol Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 57-63-6 5991
17
Polyestradiol phosphate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 28014-46-2
18
Exenatide Approved, Investigational Phase 4,Phase 3,Phase 2 141758-74-9 15991534
19
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 1,Phase 2 9004-61-9 53477741
20
Danazol Approved Phase 4 17230-88-5 28417
21
Etoricoxib Approved, Investigational Phase 4 202409-33-4 123619
22
Hydroxocobalamin Approved Phase 4,Not Applicable 13422-51-0 11953898 44475014
23
Tamoxifen Approved Phase 4,Phase 3 10540-29-1 2733526
24
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable,Early Phase 1 50-02-2 5743
25
Liraglutide Approved Phase 4 204656-20-2 44147092
26
Citalopram Approved Phase 4 59729-33-8 2771
27
Moxonidine Approved, Investigational Phase 4 75438-57-2 4810
28
Acarbose Approved, Investigational Phase 4,Not Applicable 56180-94-0 441184
29
Rosiglitazone Approved, Investigational Phase 4,Not Applicable 122320-73-4 77999
30
Leuprolide Approved, Investigational Phase 4,Phase 2,Not Applicable,Early Phase 1 53714-56-0 3911 657181
31
Epinephrine Approved, Vet_approved Phase 4,Not Applicable,Early Phase 1 51-43-4 5816
32
Acetylcysteine Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 616-91-1 12035
33
Medroxyprogesterone acetate Approved, Investigational Phase 4,Not Applicable 71-58-9
34
Alogliptin Approved Phase 4 850649-61-5 11450633
35
Menotropins Approved Phase 4,Phase 1,Phase 2 61489-71-2, 9002-68-0 5360545
36
Racepinephrine Approved Phase 4,Not Applicable,Early Phase 1 329-65-7 838
37
Desogestrel Approved Phase 4,Phase 3 54024-22-5 40973
38
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
39
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
40
Toremifene Approved, Investigational Phase 4 89778-26-7 3005573
41
Nitrous oxide Approved, Vet_approved Phase 4 10024-97-2 948
42
leucovorin Approved, Nutraceutical Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 58-05-9 143 6006
43
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1406-16-2
44
Citric Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 77-92-9 311
45
Melatonin Approved, Nutraceutical, Vet_approved Phase 4,Not Applicable 73-31-4 896
46
Vitamin D3 Approved, Nutraceutical Phase 4,Phase 3,Not Applicable 67-97-0 6221 5280795
47
Ergocalciferol Approved, Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-14-6 5280793
48
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 59-30-3 6037
49
Nicotinamide Approved, Investigational, Nutraceutical Phase 4 98-92-0 936
50
Methylcobalamin Approved, Experimental, Investigational, Nutraceutical Phase 4,Not Applicable 13422-55-4

Interventional clinical trials:

(show top 50) (show all 550)
# Name Status NCT ID Phase Drugs
1 The Impact on Ovarian Reserve After Single-port, Two-port, or Four-port Access Laparoscopic Ovarian Cyst Enucleation Unknown status NCT01631253 Phase 4
2 Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants Unknown status NCT02027337 Phase 4 20 mcg ethinylestradiol /3 mg drospirenone;20 mcg ethinylestradiol/3 mg drospirenone and Selmevit;30 mcg ethinylestradiol/3 mg drospirenone;30 mcg ethinylestradiol/3 mg drospirenone and Selmevit;35 mcg ethinylestradiol/2 mg cyproterone;35 mcg ethinylestradiol/2 mg cyproterone and Selmevit
3 Myoinositol for the Treatment of Ovarian and Psychiatric Disorder in Polycystic Ovary Syndrome (PCOS) Patients Unknown status NCT01246310 Phase 4
4 Metformin in Infertile PCOS Patients Unknown status NCT00501904 Phase 4 Metformin
5 the Effect of Diane-35 Pretreatment on In-vitro Fertilization Outcome for Patients With Polycystic Ovary Syndrome Unknown status NCT01752270 Phase 4 Diane-35 pretreatment;Diane-35 pretreatment
6 Therapeutic Monitoring of Metformin in Women With Polycystic Ovary Syndrome Unknown status NCT01366391 Phase 4 Metformin
7 Endometrial Scratching During Laproscopic Ovarian Drilling in Subfertile PCOS Women Unknown status NCT02140398 Phase 4
8 Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients Unknown status NCT00417144 Phase 4 Arvekap 0.1mg (Triptorelin, Ipsen, France);Ganirelix 0.25mg (Orgalutran, Organon, The Netherlands)
9 Surgical Ovarian Drilling Versus Hormonal Treatment for Infertility Associated to PolyCystic Ovaries Syndrome (PCOS) Unknown status NCT00378729 Phase 4 Metformin and FSHr
10 Metformin and Gestational Diabetes in High-risk Patients: a RCTs Unknown status NCT00883259 Phase 4 Metformin
11 The Effect of Weight Loss on Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome (PCOS) Unknown status NCT01475019 Phase 4 Orlistat;Sibutramine
12 Strategies for Ovulation Induction in Anovulatory Infertile Patients With PCOS Unknown status NCT00461643 Phase 4 Clomiphene citrate, metformin, metformin plus clomiphene citrate, gonadotropins
13 The Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Excision of Ovarian Cyst Completed NCT00713778 Phase 4
14 A Random Clinical Trial (RCT) of the Impact of Electrocoagulation on Ovarian Reserve Completed NCT00746278 Phase 4
15 Clinical Evaluation of Furocyst in Patients With Poly Cystic Ovary Syndrome Completed NCT02789488 Phase 4
16 The Role of Estrogen in Luteinizing Hormone Surge and Ovulation Completed NCT01999569 Phase 4 Letrozole
17 Danazol Treatment in Endometriosis Women Before IVF Completed NCT01779232 Phase 4 Danazol;placebo
18 Pain Post Abdominal Laparoscopy Prevention With Arcoxia Completed NCT00565682 Phase 4 etoricoxib 120 mg
19 FSH/LH Ratio as a Predictor of IVF Outcome in Young and Older Women Completed NCT02674178 Phase 4
20 Effects of Metformin Plus Simvastatin on Polycystic Ovarian Syndrome (PCOS): A Prospective, Randomized, Double-Blind, Placebo-Controlled Study Completed NCT01021579 Phase 4 Metformin plus Placebo;Metfomin plus Simvastatin
21 The Effect of Ethinyl Estradiol on Polycystic Ovary Syndrome Women Undergoing Intrauterine Insemination Completed NCT01219101 Phase 4 clomiphene citrate with ethinyl esteradiol;clomiphene citrate with plasebo
22 Sitagliptin Improved Beta Cell Function and Prevented a Conversion Rate to Impaired Glucose Tolerance and Type 2 Diabetes in Metformin Intolerant Obese Women With Polycystic Ovary Syndrome Completed NCT03122041 Phase 4 Sitagliptin
23 Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss Completed NCT02941445 Phase 4 sitagliptin and metformin;Metformin
24 The Effect of Metformin on Different Hormones in PCOS Patients Completed NCT02568488 Phase 4 Metformin
25 Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary Syndrome Completed NCT02483299 Phase 4 Metformin;Glucophage tablets and Victoza
26 Phytoestrogens as an Alternative to Estradiol in Ovulation Induction in PCOS Completed NCT02352597 Phase 4 phytoestrogen;estradiol valerate;clomiphene citrate
27 PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome Completed NCT02187250 Phase 4 metformin;liraglutide;roflumilast
28 PDE-4 Inhibitor Roflumilast and Polycystic Ovary Syndrome Completed NCT02037672 Phase 4 metformin;metformin and roflumilast
29 Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on Metformin Completed NCT01911468 Phase 4 metformin;liraglutide;metformin and liraglutide
30 Polycystic Ovary Syndrome and Liraglutide Completed NCT01899430 Phase 4 liraglutide;metformin
31 Vitamin D Treatment, Pharmacogenetics and Glucose Metabolism Completed NCT01721915 Phase 4 Vitamin D supplementation;Placebo
32 Medical Nutrition Therapy Plus Transgestational Metformin For Preventing Gestational Diabetes In High Risk Mexican Women Completed NCT01675310 Phase 4 medical nutrition therapy + metformin
33 hMG or Recombinant FSH on OHSS Prevention in PCOS Patients Undergoing IVF Completed NCT01365936 Phase 4 HMG;rFSH
34 The Effect of a Liraglutide on IVF in Obese PCOS Completed NCT03353948 Phase 4 MET;COMBI
35 Oral Contraceptive and Cardiovascular Risk in PCOS Completed NCT00593294 Phase 4 OC - Drospirenone plus Ethynylestradiol
36 The Effects of OCP and Metformin on Clinical, Hormonal, Metabolic and Ultrasonographic Characteristics in PCOS Completed NCT02866786 Phase 4 Metformin;ethinyl estradiol and cyproterone acetate
37 Metformin and Oral Contraceptives in PCOS Completed NCT00451568 Phase 4 Metformin;Desorelle
38 The Effects of Vitamin D on Transforming Growth Factor-beta1 in Polycystic Ovary Syndrome Completed NCT02460380 Phase 4 Vitamin D3
39 Trial With Metformin in Women With Polycystic Ovary Syndrome Completed NCT02280057 Phase 4 Metformin;Placebo
40 N-acetyl Cysteine for Ovulation Induction in Clomiphene Citrate Resistant Polycystic Ovary Syndrome Completed NCT02239107 Phase 4 N-Acetyl cysteine
41 LIPT - Liraglutide in Polycystic Ovary Syndrome Completed NCT02073929 Phase 4 Liraglutide;placebo
42 The Effect of Cipralex on Quality of Life, Adrenal Activity Glucose Metabolism, Physical and Mental Health in PCOS Completed NCT01961180 Phase 4 Cipralex;Placebo
43 Comparison of Alogliptin Versus Alogliptin and Pioglitazone on Insulin Resistance of Metformin Treated Women With PCOS Completed NCT02683226 Phase 4 Vipdomet;Incresync
44 Role of Melatonin Supplementation in Follicular Fluid of in Vitro Fertilization (IVF) Patients With Polycystic Ovarian Syndrome Completed NCT01540747 Phase 4
45 Polycystic Ovary Syndrome - Improving Outcomes Completed NCT01504321 Phase 4 Moxonidine;Placebo
46 Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism Completed NCT01360996 Phase 4 3 mg DRSP/20 μg EE
47 Metformin Versus Acarbose Treatment in Infertile Overweight Women With Polycystic Ovary Syndrome (PCOS) Completed NCT01279512 Phase 4 Metformin;Acarbose
48 Effect of Nicotinic Acid on Cardiovascular Risks Indices in Polycystic Ovary Syndrome Completed NCT01118598 Phase 4 tredaptive (nicotinic acid/ laropiprant);placebo
49 Metformin and Folate in Pregnant Polycystic Ovary Syndrome(PCOS) Women Completed NCT01115140 Phase 4 metformin plus placebo;Metformin plus folic acid;placebo plus folic acid;placebo alone
50 Short-term Structured Exercise Training Program Plus Diet Intervention in Patients With Polycystic Ovary Syndrome (PCOS) Completed NCT01004068 Phase 4 Clomiphene citrate

Search NIH Clinical Center for Ovarian Cyst

Genetic Tests for Ovarian Cyst

Genetic tests related to Ovarian Cyst:

# Genetic test Affiliating Genes
1 Ovarian Cyst 29

Anatomical Context for Ovarian Cyst

MalaCards organs/tissues related to Ovarian Cyst:

41
Ovary, Liver, Bone, Brain, Heart, Prostate, Endothelial

Publications for Ovarian Cyst

Articles related to Ovarian Cyst:

(show top 50) (show all 634)
# Title Authors Year
1
The effects of sclerotherapy with 5% trichloroacetic acid on the cyst diameter and ovarian tissue in the rat ovarian cyst model. ( 29564948 )
2018
2
Vaginal bleeding and a giant ovarian cyst in an infant with 21-hydroxylase deficiency. ( 29252197 )
2018
3
Omental fat necrosis without torsion mimicking ovarian cyst torsion. ( 29685724 )
2018
4
Ovarian cyst removal influences ovarian reserve dependent on histology, size and type of operation. ( 29806554 )
2018
5
A Giant Ovarian Cyst in an Adolescent. ( 29731358 )
2018
6
High Frequency of Ovarian Cyst Development in Vhl<sup>2B/+</sup>;Snf5<sup>+/-</sup> Mice. ( 29684361 )
2018
7
Impending abdominal compartment syndrome from a giant ovarian cyst torsion. ( 28922702 )
2017
8
Case Report of Clitoral Hypertrophy in 2 Extremely Premature Girls With an Ovarian Cyst. ( 28931575 )
2017
9
Performance of ovarian cyst fluid fine-needle aspiration cytology. ( 28834408 )
2017
10
Haemoperitoneum due to ruptured ovarian cyst in a 13-year-old girl with factor V deficiency- A case report. ( 28138193 )
2017
11
Laparoscopic Management of a Giant Ovarian Cyst in a Premenarchal Girl. ( 28104495 )
2017
12
A Wandering Abdominal Mass in a Neonate: An Enteric Duplication Cyst Mimicking an Ovarian Cyst. ( 28348910 )
2017
13
Diagnostic accuracy of haptoglobin within ovarian cyst fluid as a potential point-of-care test for epithelial ovarian cancer: an observational study. ( 28755436 )
2017
14
Complete Laparoscopic Extirpation of a Giant Ovarian Cyst in an Adolescent. ( 28840047 )
2017
15
Presacral mass in the setting of an ovarian cyst and abdominal pain. ( 28659365 )
2017
16
Enormous Ovarian Cyst. ( 29021455 )
2017
17
Giant ovarian cyst masquerading as a massive ascites: a case report. ( 29258579 )
2017
18
Hemorrhage in a Fetal Ovarian Cyst. ( 28770146 )
2017
19
LncRNAs expression profiling in normal ovary, benign ovarian cyst and malignant epithelial ovarian cancer. ( 27941916 )
2016
20
EP22.08: Personalised 3D model for fetal ovarian cyst: a case report. ( 27646615 )
2016
21
Unusual presentation of twisted ovarian cyst. ( 27134479 )
2016
22
Large ovarian cyst with torsion. ( 27531002 )
2016
23
Occasional finding of giant bladder diverticulum that simulated an ovarian cyst: A case report and literature review. ( 26787074 )
2016
24
Hydronephrosis caused by a giant ovarian cyst. ( 27564301 )
2016
25
Diagnostic potential of tumor DNA from ovarian cyst fluid. ( 27421040 )
2016
26
Borderline Brenner tumors associated with ovarian cyst - case presentation. ( 27833989 )
2016
27
Postoperative AMH reduction is not associated with reduced fecundity two years following ovarian cyst surgery. ( 27028572 )
2016
28
Rocuronium and sugammadex in a 3 days old neonate for draining an ovarian cyst. Neuromuscular management and review of the literature. ( 27343797 )
2016
29
Torsion, infarction, and rupture of a nongravid uterus: a complication of a large ovarian cyst. ( 27251733 )
2016
30
Poster 167 Ovarian Cyst Rupture as an Unusual Etiology for Hip Pain in a Young Female Runner: A Case Report. ( 27672931 )
2016
31
The improvement of hirsutism and the decrease of testosterone concentration in the peripheral blood serum after removing an endometrioid ovarian cyst. ( 27328515 )
2016
32
Role of benign ovarian cysts in the development of adenomyosis. ( 27570851 )
2016
33
Papillary Serous Carcinoma of the Peritoneum mimicking Ovarian cyst in Pregnancy. ( 27133555 )
2016
34
Hemolymphangioma of the broad ligament: A differential diagnosis for an ovarian cyst. ( 27558953 )
2016
35
Large hemorrhagic ovarian cyst in postmenopausal patient with autosomal dominant polycystic kidney disease. ( 27795640 )
2016
36
Appendix mucocele mimicking a complex ovarian cyst. ( 25931937 )
2015
37
Conservative management of a large neonatal ovarian cyst: a case report. ( 26023615 )
2015
38
Percutaneous Drainage of a Rapidly Enlarging Simple Ovarian Cyst in the Third Trimester. ( 26444478 )
2015
39
Giant Ovarian Cyst Masquerading as Massive Ascites in an 11-Year-Old. ( 26236528 )
2015
40
Prenatal and postnatal ultrasonographic findings of the torsioned ovarian cyst: a case report and brief literature review. ( 25785337 )
2015
41
Unusual Presentation of an Ovarian Cyst: Successful Laparoscopic Excision. ( 27678805 )
2015
42
Telelap Alf-X-Assisted Laparoscopy for Ovarian Cyst Enucleation: Report of the First 10 Cases. ( 25987523 )
2015
43
Complex fetal ovarian cyst. ( 25911726 )
2015
44
Ovarian Cyst Aspiration in the Neonate: Minimally Invasive Surgery. ( 26148782 )
2015
45
Post-Operative Analgesia after Laparoscopic Ovarian Cyst Resection: Double Blind Multicenter Randomized Control trial comparing Intraperitoneal Nebulization and Peritoneal Instillation of Ropivacaine. ( 25820113 )
2015
46
Transfundal puncture of a large ovarian cyst with hysteroscopic and ultrasonographic guidance. ( 25999768 )
2015
47
Comparison of anti-mullerian hormone level in non-endometriotic benign ovarian cyst before and after laparoscopic cystectomy. ( 26000005 )
2015
48
Ovarian Cyst Saline Distention to Enhance Dissection Planes Upon Cystectomy. ( 27678824 )
2015
49
Neurogenic Ovarian Cyst--A Rare, Monodermal Teratoma. ( 26261871 )
2015
50
Torsed large prenatally detected foetal ovarian cyst. ( 25671519 )
2015

Variations for Ovarian Cyst

ClinVar genetic disease variations for Ovarian Cyst:

6
# Gene Variation Type Significance SNP ID Assembly Location
1 46;XX;ins(5;6)(p13;p24p25)dn Translocation Pathogenic

Expression for Ovarian Cyst

Search GEO for disease gene expression data for Ovarian Cyst.

Pathways for Ovarian Cyst

Pathways related to Ovarian Cyst according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.27 GSTP1 PLAT VEGFA
2 11.13 PLAT VEGFA
3 10.95 PLAT VEGFA
4 10.41 PLAT VEGFA
5 9.74 PLAT SERPINB2

GO Terms for Ovarian Cyst

Cellular components related to Ovarian Cyst according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.5 AFP GSTP1 MUC16 PLAT PRL SERPINB2
2 extracellular space GO:0005615 9.17 AFP GSTP1 MUC16 PLAT PRL SERPINB2

Biological processes related to Ovarian Cyst according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 response to nutrient levels GO:0031667 9.26 GSTP1 PRL
2 lactation GO:0007595 9.16 PRL VEGFA
3 ovarian follicle development GO:0001541 8.96 FOXL2 VEGFA
4 fibrinolysis GO:0042730 8.62 PLAT SERPINB2

Sources for Ovarian Cyst

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....